(MedPage Today) — Initiation of a GLP-1 receptor agonist was tied to lower risks of several substance use disorders (SUDs) in adults with type 2 diabetes, according to a target trial emulation using data on veterans.
In patients without a history…
Source link : https://www.medpagetoday.com/psychiatry/addictions/120182
Author :
Publish date : 2026-03-05 20:53:00
Copyright for syndicated content belongs to the linked Source.
